Saint Luke’s seeks qualified applicants for cardiovascular outcomes fellowships
T32 grant funding trains next generation of leaders in clinical and outcomes research
KANSAS CITY, Mo., Jan. 2, 2013 /PRNewswire-USNewswire/ — As one of the leading outcomes research centers in the nation, Saint Luke’s Mid America Heart Institute has led more than 115 clinical trials in all aspects of cardiovascular disease. The Heart Institute, based in Kansas City, invites applications for a two-year postdoctoral training program in cardiovascular outcomes research. The T32 training program, funded by the National Heart Lung and Blood Institute to the University of Missouri-Kansas City (UMKC), is hosted by the Mid America Heart Institute in close collaboration with the University of Kansas.
“There is a growing regional and national need for more scholars in cardiovascular outcomes and quality of care research,” said John Spertus, M.D., Daniel J. Lauer/Missouri Endowed Chair and Professor at the UMKC School of Medicine and Clinical Director of Outcomes Research at Saint Luke’s Mid America Heart Institute. “This fellowship provides curriculum, mentored research, and independent research experiences to train the next generation of leaders in the fields of cardiovascular clinical and outcomes research.”
The program is designed to train young scholars in quantifying patients’ outcomes, defining the determinants of these outcomes, comparing the effectiveness of alternative treatments, translating new knowledge into clinical care, and measuring and improving the quality of care.
For program details and eligibility requirements, visit http://bit.ly/YGZXpm.
About Saint Luke’s Mid America Heart Institute
Saint Luke’s Mid America Heart Institute, a member of Saint Luke’s Health System and a teaching affiliate of the University of Missouri-Kansas City, is one of the preeminent cardiovascular programs in the country. Its legacy of innovation began more than 25 years ago when it opened as the nation’s first heart hospital. Since then, the Heart Institute has earned a world-wide reputation for excellence in the treatment of heart disease, including interventional cardiology, cardiovascular surgery, imaging, heart failure, transplant, heart disease prevention, women’s heart disease, electrophysiology, outcomes research, and health economics. With more than 50 full-time board certified cardiovascular specialists on staff, the Heart Institute offers one of the largest heart failure/heart transplant programs in the country, has the largest experience with transcatheter aortic valve replacement in the Midwest, and is a global teaching site for the newest approaches to opening challenging blocked arteries using minimally invasive techniques.
SOURCE Saint Luke’s Health System